Corrigendum to “Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells” [Mol Metab 2016 May; 5 (5): 366–378] (Molecular Metabolism (2016) 5(5) (366–378), (S2212877816000211), (10.1016/j.molmet.2016.01.009));Inter-domain tagging implicates caveolin-1 in insulin receptor trafficking and Erk signaling bias in pancreatic beta-cells

Molecular Metabolism

Volumn 5, Issue 5, 2016, Pages 366-378

  Boothe, Tobias ^a   Lim, Gareth E ^a   Cen, Haoning ^a   Skovsø, Søs ^a   Piske, Micah ^a   Li, Shu Nan ^a   Nabi, Ivan R ^a   Gilon, Patrick ^b   Johnson, James D ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Autocrine insulin signaling; Insulin receptor internalization; Insulin resistance; Pancreatic islet beta cells

Indexed keywords

CAVEOLIN 1; FLOTILLIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; INSULIN RECEPTOR; INSULIN RECEPTOR ANTIBODY; MITOGEN ACTIVATED PROTEIN KINASE; RAB5A PROTEIN; RAB7 PROTEIN; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL MIGRATION; CONTROLLED STUDY; ENDOCYTOSIS; ENDOSOME; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INTERNALIZATION; LYSOSOME; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 84963613030     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2024.101935     Document Type: Erratum

References (73)

1. Okada T., Liew C.W., Hu J., Hinault C., Michael M.D., Krtzfeldt J., et al. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:8977-8982.
2. Leibiger I.B., Leibiger B., Berggren P.O. Insulin signaling in the pancreatic beta-cell. Annual Review of Nutrition 2008, 28:233-251.
3. Johnson J.D., Alejandro E.U. Control of pancreatic beta-cell fate by insulin signaling: the sweet spot hypothesis. Cell Cycle 2008, 7:1343-1347.
4. Mehran A.E., Templeman N.M., Brigidi G.S., Lim G.E., Chu K.Y., Hu X., et al. Hyperinsulinemia drives diet-induced obesity independently of brain insulin production. Cell Metabolism 2012, 16:723-737.
5. Johnson J.D., Bernal-Mizrachi E., Alejandro E.U., Han Z., Kalynyak T.B., Li H., et al. Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proceedings of the National Academy of Sciences of the United States of America 2006, 103:19575-19580.
6. Alejandro E.U., Lim G.E., Mehran A.E., Hu X., Taghizadeh F., Pelipeychenko D., et al. Pancreatic beta-cell Raf-1 is required for glucose tolerance, insulin secretion, and insulin 2 transcription. FASEB Journal 2011, 25:3884-3895.
7. Beith J.L., Alejandro E.U., Johnson J.D. Insulin stimulates primary beta-cell proliferation via Raf-1 kinase. Endocrinology 2008, 149:2251-2260.
8. Posner B.I., Kahn M.N., Bergeron J.J. Internalization of insulin: structures involved and significance. Advances in Experimental Medicine and Biology 1985, 189:159-173.
9. Lajoie P., Nabi I.R. Lipid rafts, caveolae, and their endocytosis. International Review of Cell and Molecular Biology 2010, 282:135-163.
10. Parton R.G., del Pozo M.A. Caveolae as plasma membrane sensors, protectors and organizers. Nature Reviews Molecular Cell Biology 2013, 14:98-112.
11. Smith R.M., Harada S., Smith J.A., Zhang S., Jarett L. Insulin-induced protein tyrosine phosphorylation cascade and signalling molecules are localized in a caveolin-enriched cell membrane domain. Cell Signal 1998, 10:355-362.
12. Kabayama K., Sato T., Saito K., Loberto N., Prinetti A., Sonnino S., et al. Dissociation of the insulin receptor and caveolin-1 complex by ganglioside GM3 in the state of insulin resistance. Proceedings of the National Academy of Sciences of the United States of America 2007, 104:13678-13683.
13. Fagerholm S., Ortegren U., Karlsson M., Ruishalme I., Strålfors P. Rapid insulin-dependent endocytosis of the insulin receptor by caveolae in primary adipocytes. PLoS ONE 2009, 4:e5985.
14. Ceresa B.P., Kao A.W., Santeler S.R., Pessin J.E. Inhibition of clathrin-mediated endocytosis selectively attenuates specific insulin receptor signal transduction pathways. Molecular and Cellular Biology 1998, 18:3862-3870.
15. Cohen A.W., Razani B., Wang X.B., Combs T.P., Williams T.M., Scherer P.E., et al. Caveolin-1-deficient mice show insulin resistance and defective insulin receptor protein expression in adipose tissue. American Journal of Physiology. Cell Physiology 2003, 285:C222-C235.
16. Razani B., Combs T.P., Wang X.B., Frank P.G., Park D.S., Russell R.G., et al. Caveolin-1-deficient mice are lean, resistant to diet-induced obesity, and show hypertriglyceridemia with adipocyte abnormalities. Journal of Biological Chemistry 2002, 277:8635-8647.
17. Trajkovski M., Hausser J., Soutschek, Bhat B., Akin A., Zavolan M., et al. MicroRNAs 103 and 107 regulate insulin sensitivity. Nature 2011, 474:649-653.
18. Uhles S., Moede T., Leibiger B., Berggren P.-O., Leibiger I.B. Selective gene activation by spatial segregation of insulin receptor B signaling. FASEB Journal 2007, 21:1609-1621.
19. Uhles S., Moede T., Leibiger B., Berggren P.-O., Leibiger I.B. Isoform-specific insulin receptor signaling involves different plasma membrane domains. The Journal of Cell Biology 2003, 163:1327-1337.
20. Belfiore A., Frasca F., Pandini G., Sciacca L., Vigneri R. Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease. Endocrine Reviews 2009, 30:586-623.
21. De Meyts P., Whittaker J. Structural biology of insulin and IGF1 receptors: implications for drug design. Nature Reviews Drug Discovery 2002, 1:769-783.
22. Gerdes J.M., Christou-Savina S., Xiong Y., Moede T., Moruzzi N., Karlsson-Edlund P., et al. Ciliary dysfunction impairs beta-cell insulin secretion and promotes development of type 2 diabetes in rodents. Nature Communications 2014, 5:5308.
23. Alejandro E.U., Kalynyak T.B., Taghizadeh F., Gwiazda K.S., Rawstron E.K., Jacob K.J., et al. Acute insulin signaling in pancreatic beta-cells is mediated by multiple Raf-1 dependent pathways. Endocrinology 2010, 151:502-512.
24. Goetz J.G., Lajoie P., Wiseman S.M., Nabi I.R. Caveolin-1 in tumor progression: the good, the bad and the ugly. Cancer Metastasis Reviews 2008, 27:715-735.
25. Vicidomini G., Moneron G., Han K.Y., Westphal V., Ta H., Reuss M., et al. Sharper low-power STED nanoscopy by time gating. Nature Methods 2011, 8:571-573.
26. Schindelin J., Arganda-Carreras I., Frise E., Kaynig V., Longair M., Pietzsch T., et al. Fiji: an open-source platform for biological-image analysis. Nature Methods 2012, 9:676-682.
27. Thevenaz P., Ruttimann U.E., Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Transactions on Image Processing: A Publication of the IEEE Signal Processing Society 1998, 7:27-41.
28. Sternberg S.R. Biomedical Image-Processing. Computer 1983, 16:22-34.
29. Bolte S., Cordelieres F.P. A guided tour into subcellular colocalization analysis in light microscopy. Journal of Microscopy 2006, 224:213-232.
30. Lamprecht M.R., Sabatini D.M., Carpenter A.E. CellProfiler: free, versatile software for automated biological image analysis. Biotechniques 2007, 42:71-75.
31. Drab M., Verkade P., Elger M., Kasper M., Lohn M., Lauterbach B., et al. Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice. Science 2001, 293:2449-2452.
32. Nelson J.D., LeBoeuf R.C., Bomsztyk K. Direct recruitment of insulin receptor and ERK signaling cascade to insulin-inducible gene loci. Diabetes 2011, 60:127-137.
33. Saltiel A.R., Pessin J.E. Insulin signaling in microdomains of the plasma membrane. Traffic 2003, 4:711-716.
34. McClain D.A. Mechanism and role of insulin receptor endocytosis. American Journal of the Medical Sciences 1992, 304:192-201.
35. Leibiger I.B., Brismar K., Berggren P.-O. Novel aspects on pancreatic beta-cell signal-transduction. Biochemical and Biophysical Research 2010, 396:111-115.
36. Huang B., Babcock H., Zhuang X. Breaking the diffraction barrier: super-resolution imaging of cells. Cell 2010, 143:1047-1058.
37. Merzlyak E.M., Goedhart J., Shcherbo D., Bulina M.E., Shcheglov A.S., Fradkov A.F., et al. Bright monomeric red fluorescent protein with an extended fluorescence lifetime. Nature Methods 2007, 4:555-557.
38. Subach O.M., Gundorov I.S., Yoshimura M., Subach F.V., Zhang J., Grüenwald D., et al. Conversion of red fluorescent protein into a bright blue probe. Chemistry & Biology 2008, 15:1116-1124.
39. Zeigerer A., Gilleron J., Bogorad R.L., Marsico G., Nonaka H., Seifert S., et al. Rab5 is necessary for the biogenesis of the endolysosomal system in vivo. Nature 2012, 485:465-470.
40. Veluthakal R., Chvyrkova I., Tannous M., McDonald P., Amin R., Hadden T., et al. Essential role for membrane lipid rafts in interleukin-1beta-induced nitric oxide release from insulin-secreting cells: potential regulation by caveolin-1+. Diabetes 2005, 54:2576-2585.
41. Nevins A.K., Thurmond D.C. Caveolin-1 functions as a novel Cdc42 guanine nucleotide dissociation inhibitor in pancreatic beta-cells. The Journal of Biological Chemistry 2006, 281:18961-18972.
42. Kimura A., Mora S., Shigematsu S., Pessin J.E., Saltiel A.R. The insulin receptor catalyzes the tyrosine phosphorylation of caveolin-1. Journal of Biological Chemistry 2002, 277:30153-30158.
43. Glebov O.O., Bright N.A., Nichols B.J. Flotillin-1 defines a clathrin-independent endocytic pathway in mammalian cells. Nature Cell Biology 2006, 8:46-54.
44. Bickel P.E., Scherer P.E., Schnitzer J.E., Oh P., Lisanti M.P., Lodish H.F. Flotillin and epidermal surface antigen define a new family of caveolae-associated integral membrane proteins. Journal of Biological Chemistry 1997, 272:13793-13802.
45. Baumann C.A., Ribon V., Kanzaki M., Thurmond D.C., Mora S., Shigematsu S., et al. CAP defines a second signalling pathway required for insulin-stimulated glucose transport. Nature 2000, 407:202-207.
46. Liu J., Deyoung S.M., Zhang M., Dold L.H., Saltiel A.R. The stomatin/prohibitin/flotillin/HflK/C domain of flotillin-1 contains distinct sequences that direct plasma membrane localization and protein interactions in 3T3-L1 adipocytes. Journal of Biological Chemistry 2005, 280:16125-16134.
47. Mundy D.I., Li W.P., Luby-Phelps K., Anderson R.G. Caveolin targeting to late endosome/lysosomal membranes is induced by perturbations of lysosomal pH and cholesterol content. Molecular Biology of the Cell 2012, 23:864-880.
48. Hayer A., Stoeber M., Ritz D., Engel S., Meyer H.H., Helenius A. Caveolin-1 is ubiquitinated and targeted to intralumenal vesicles in endolysosomes for degradation. Journal of Cell Biology 2010, 191:615-629.
49. Li S., Seitz R., Lisanti M.P. Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo. Journal of Biological Chemistry 1996, 271:3863-3868.
50. Wang M., Li J., Lim G.E., Johnson J.D. Is dynamic autocrine insulin signaling possible? A mathematical model predicts picomolar concentrations of extracellular monomeric insulin within human pancreatic islets. PLoS ONE 2013, 8:e64860.
51. Ohsugi M., Cras-Meneur C., Zhou Y., Bernal-Mizrachi E., Johnson J.D., Luciani D.S., et al. Reduced expression of the insulin receptor in mouse insulinoma (MIN6) cells reveals multiple roles of insulin signaling in gene expression, proliferation, insulin content, and secretion. Journal of Biological Chemistry 2005, 280:4992-5003.
52. Gunton J.E., Kulkarni R.N., Yim S., Okada T., Hawthorne W.J., Tseng Y.H., et al. Loss of ARNT/HIF1beta Mediates Altered Gene Expression and Pancreatic-Islet Dysfunction in Human Type 2 Diabetes. Cell 2005, 122:337-349.
53. Folli F., Okada T., Perego C., Gunton J., Liew C.W., Akiyama M., et al. Altered insulin receptor signalling and beta-cell cycle dynamics in type 2 diabetes mellitus. PLoS ONE 2011, 6:e28050.
54. Zhao J., Zhang N., He M., Yang Z., Tong W., Wang Q., et al. Increased beta-cell apoptosis and impaired insulin signaling pathway contributes to the onset of diabetes in OLETF rats. Cellular Physiology and Biochemistry 2008, 21:445-454.
55. Wang M., Li J., Lim G.E., Johnson J.D. Is dynamic autocrine insulin signaling possible? A mathematical model predicts picomolar concentrations of extracellular monomeric insulin within human pancreatic islets. PLoS ONE 2013, in press.
56. Gao X., Lowry P.R., Zhou X., Depry C., Wei Z., Wong G.W., et al. PI3K/Akt signaling requires spatial compartmentalization in plasma membrane microdomains. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:14509-14514.
57. Wang P.Y., Weng J., Anderson R.G. OSBP is a cholesterol-regulated scaffolding protein in control of ERK 1/2 activation. Science 2005, 307:1472-1476.
58. Lidke D.S., Huang F., Post J.N., Rieger B., Wilsbacher J., Thomas J.L., et al. ERK nuclear translocation is dimerization-independent but controlled by the rate of phosphorylation. Journal of Biological Chemistry 2010, 285:3092-3102.
59. Kepner E.M., Yoder S.M., Oh E., Kalwat M.A., Wang Z., Quilliam L.A., et al. Cool-1/betaPIX functions as a guanine nucleotide exchange factor in the cycling of Cdc42 to regulate insulin secretion. American journal of physiology. Endocrinology and Metabolism 2011, 301:E1072-E1080.
60. Pojoga L.H., Underwood P.C., Goodarzi M.O., Williams J.S., Adler G.K., Jeunemaitre X., et al. Variants of the caveolin-1 gene: a translational investigation linking insulin resistance and hypertension. The Journal of Clinical Endocrinology and Metabolism 2011, 96:E1288-E1292.
61. Asterholm I.W., Mundy D.I., Weng J., Anderson R.G., Scherer P.E. Altered mitochondrial function and metabolic inflexibility associated with loss of caveolin-1. Cell Metabolism 2012, 15:171-185.
62. Cohen A.W., Razani B., Schubert W., Williams T.M., Wang X.B., Iyengar P., et al. Role of caveolin-1 in the modulation of lipolysis and lipid droplet formation. Diabetes 2004, 53:1261-1270.
63. Gustavsson J., Parpal S., Karlsson M., Ramsing C., Thorn H., Borg M., et al. Localization of the insulin receptor in caveolae of adipocyte plasma membrane. FASEB Journal 1999, 13:1961-1971.
64. Gomez-Ruiz A., de Miguel C., Campion J., Martinez J.A., Milagro F.I. Time-dependent regulation of muscle caveolin activation and insulin signalling in response to high-fat diet. FEBS Letters 2009, 583:3259-3264.
65. Oh Y.S., Khil L.Y., Cho K.A., Ryu S.J., Ha M.K., Cheon G.J., et al. A potential role for skeletal muscle caveolin-1 as an insulin sensitivity modulator in ageing-dependent non-obese type 2 diabetes: studies in a new mouse model. Diabetologia 2008, 51:1025-1034.
66. Wang H., Wang A.X., Barrett E.J. Caveolin-1 is required for vascular endothelial insulin uptake. American Journal of Physiology Endocrinology and Metabolism 2011, 300:E134-E144.
67. Le P.U., Guay G., Altschuler Y., Nabi I.R. Caveolin-1 is a negative regulator of caveolae-mediated endocytosis to the endoplasmic reticulum. Journal of Biological Chemistry 2002, 277:3371-3379.
68. Cheng Z.-J., Singh R.D., Holicky E.L., Wheatley C.L., Marks D.L., Pagano R.E. Co-regulation of caveolar and Cdc42-dependent fluid phase endocytosis by Phosphocaveolin-1. Journal of Biological Chemistry 2010, 285:15119-15125.
69. Baens M., Noels H., Broeckx V., Hagens S., Fevery S., Billiau A.D., et al. The dark side of EGFP: defective polyubiquitination. PLoS ONE 2006, 1:e54.
70. Ketelaar T., Anthony R.G., Hussey P.J. Green fluorescent protein-mTalin causes defects in actin organization and cell expansion in Arabidopsis and inhibits actin depolymerizing factor's actin depolymerizing activity in vitro. Plant Physiology 2004, 136:3990-3998.
71. Matthews L.C., Taggart M.J., Westwood M. Modulation of caveolin-1 expression can affect signalling through the phosphatidylinositol 3-kinase/Akt pathway and cellular proliferation in response to insulin-like growth factor I. Endocrinology 2008, 149:5199-5208.
72. Baehler P.J., Biondi R.M., van Bemmelen M., Veron M., Reymond C.D. Random insertion of green fluorescent protein into the regulatory subunit of cyclic adenosine monophosphate-dependent protein kinase. Methods in Molecular Biology 2002, 183:57-68.
73. Rocheleau J.V., Edidin M., Piston D.W. Intrasequence GFP in class I MHC molecules, a rigid probe for fluorescence anisotropy measurements of the membrane environment. Biophysical Journal 2003, 84:4078-4086.